Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Gross Profit (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Gross Profit for 6 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 52.02% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.5 million through Dec 2025, up 45.45% year-over-year, with the annual reading at $21.5 million for FY2025, 45.45% up from the prior year.
  • Gross Profit hit $8.0 million in Q4 2025 for Rapid Micro Biosystems, up from $4.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $8.0 million in Q4 2025 to a low of $250000.0 in Q4 2022.
  • Historically, Gross Profit has averaged $3.0 million across 5 years, with a median of $2.9 million in 2021.
  • Biggest five-year swings in Gross Profit: tumbled 87.5% in 2022 and later soared 1170.4% in 2023.
  • Year by year, Gross Profit stood at $1.9 million in 2021, then tumbled by 86.51% to $250000.0 in 2022, then skyrocketed by 1170.4% to $3.2 million in 2023, then soared by 64.86% to $5.2 million in 2024, then surged by 52.02% to $8.0 million in 2025.
  • Business Quant data shows Gross Profit for RPID at $8.0 million in Q4 2025, $4.9 million in Q3 2025, and $4.1 million in Q2 2025.